|
FY2026
12 months to Jul 31, 2026
|
FY2025
12 months to Jul 31, 2025
|
FY2024
12 months to Jul 31, 2024
|
FY2023
12 months to Jul 31, 2023
|
FY2022
12 months to Jul 31, 2022
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Gain on sale of business | |||||
| Deferred income taxes | |||||
| Other | |||||
| Changes in operating assets and liabilities (net of effects of business acquisitions): | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Income taxes | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Sale of business | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Payment of dividends | |||||
| Proceeds from exercise of stock options | |||||
| Payments for employee taxes withheld from stock-based awards | |||||
| Purchase of treasury stock | |||||
| Proceeds from borrowing on credit facilities | |||||
| Repayments of Lines of Credit | |||||
| Other | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance | |||||
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Ending Balance | |||||
| Supplemental Cash Flow Information | |||||
| Cash interest paid | |||||
| Income taxes | |||||
Loading...